To maximise its health benefits, self‐testing for infectious diseases must be reliable, accessible, and affordable
Human immunodeficiency virus (HIV) testing is a key prevention strategy; a positive test result can lead to life‐saving antiretroviral therapy, while a negative result opens access to effective prevention measures, such as pre‐exposure prophylaxis. Home‐based testing of blood or oral secretions for HIV antibody has been available in some countries for many years. In Australia, however, only self‐testing of blood is available (since November 2018),1 and its uptake by people regularly tested for HIV has been surprisingly low (about 1%).2 With the recent widespread use of antigen tests for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2),3 home‐based testing is now quite familiar in Australia, providing an opportunity to improve the acceptability of its use for detecting other infections, including HIV.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
No relevant disclosures.